Finance

Lists
Why is IBT-B up 6.21%?
Dive Deeper
IBT-B:STO
Infant Bacterial Therapeutics AB
SEK 70.10
+6.21%
(+4.10) 1D
ኖቬም 16, 5:29:37 ከሰዓት ጂ ኤም ቲ+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for IBT-B...
Open
SEK 67.00
High
SEK 72.00
Low
SEK 67.00
Mkt. cap
912.57 ሚ
Avg. vol.
10.49 ሺ
Volume
12.24 ሺ
52-wk high
SEK 84.90
52-wk low
SEK 43.25
EPS
-SEK 6.08
Shares outstanding
13.02 ሚ
No. of employees
6
Open
SEK 67.00
High
SEK 72.00
Low
SEK 67.00
Mkt. cap
912.57 ሚ
Avg. vol.
10.49 ሺ
Volume
12.24 ሺ
52-wk high
SEK 84.90
52-wk low
SEK 43.25
EPS
-SEK 6.08
Shares outstanding
13.02 ሚ
No. of employees
6
News stories
From web sources and news partners
About Infant Bacterial Therapeutics AB
CEOStaffan Strömberg
Employees6
Founded2011
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.66 ሚ
18.69 ሚ
23.02 ሚ
18.08 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.88 ሚ
4.81 ሚ
7.09 ሚ
2.64 ሚ
Operating expense
20.54 ሚ
23.50 ሚ
30.11 ሚ
20.73 ሚ
Total operating expenses
20.54 ሚ
23.50 ሚ
30.11 ሚ
20.73 ሚ
Operating income
-20.54 ሚ
-23.50 ሚ
-30.11 ሚ
-20.73 ሚ
Other non operating income
-1.00 ሺ
-563.44 ሚ
-
-
EBT including unusual items
-19.20 ሚ
-22.94 ሚ
-29.73 ሚ
-20.46 ሚ
EBT excluding unusual items
-19.20 ሚ
-22.94 ሚ
-29.73 ሚ
-20.46 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.20 ሚ
-22.94 ሚ
-29.73 ሚ
-20.46 ሚ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.34 ሚ
564.00 ሚ
380.00 ሺ
262.00 ሺ
Interest expense
-
-
-
-
Net interest expenses
1.34 ሚ
564.00 ሚ
380.00 ሺ
262.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች